Products
Nanobody Drug Product Line
Humanized Nanobody Library Screening
Directly use humanized scaffolds to build nanobody libraries, screened molecules are final molecules, improving success rate and shortening cycles.
OncologyHigh AffinityTissue Penetration
技术参数
人源化Humanized
亲和力：
稳定性：
应用领域
Antibody DrugADCAOCCar-T
Oral Nanobody Screening
Directly use humanized + anti-gastric and intestinal protease degradation scaffolds to build nanobody libraries, while optimizing CDR sequence composition, screened molecules can be directly used for subsequent oral drug development
Immunotherapy
技术参数
人源化Resistant to pepsin, resistant to intestinal proteases
亲和力：
稳定性：
应用领域
Oral NanobodyIBD
Peptide Screening
Peptide drug screening, TCE masking peptide screening, ultra-large library capacity rapid screening, more flexible and concise than DEL, lower cost and shorter time.
Multi-Platform
技术参数
人源化In vitro screening
亲和力：
稳定性：
应用领域
Peptide Drug
R&D Pipeline
Nanobody Drug Development Progress
| Project | Indication | Format | Current Stage | Expected Milestone |
|---|---|---|---|---|
| CD71-VHH Platform | BBB shuttle | Naked VHH / Fc fusion | In vivo study | 2026 Q3 Data |
| CD71-VHH-anti-Aβ | Alzheimer's Disease | Bispecific antibody | In vivo study | 2027 Q1 IND |
| CD71-VHH-ASO | Neurodegenerative Disease | Chemical conjugation | In vivo study | 2026 Q3 POC |
| CD98hc / Dual-targeting | Platform expansion | VHH shuttle | In vitro validation | 2027-2028 |